SFBC INTERNATIONAL INC
SB-2/A, EX-27.1, 2000-07-21
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SFBC INTERNATIONAL INC, SB-2/A, EX-23.1, 2000-07-21
Next: SFBC INTERNATIONAL INC, SB-2/A, EX-27.2, 2000-07-21



<TABLE> <S> <C>

<ARTICLE>                     5

<S>                                  <C>
<PERIOD-TYPE>                        3-MOS
<FISCAL-YEAR-END>                    DEC-31-2000
<PERIOD-START>                       JAN-01-2000
<PERIOD-END>                         MAR-31-2000
<CASH>                                   561,827
<SECURITIES>                                   0
<RECEIVABLES>                          2,885,025
<ALLOWANCES>                             177,838
<INVENTORY>                                    0
<CURRENT-ASSETS>                       3,506,823
<PP&E>                                   655,440
<DEPRECIATION>                           280,453
<TOTAL-ASSETS>                         5,068,663
<CURRENT-LIABILITIES>                  2,796,838
<BONDS>                                        0
                          0
                                    0
<COMMON>                                   2,336
<OTHER-SE>                               998,686
<TOTAL-LIABILITY-AND-EQUITY>           5,068,663
<SALES>                                2,303,116
<TOTAL-REVENUES>                       2,303,116
<CGS>                                  1,468,858
<TOTAL-COSTS>                            534,632
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                        24,122
<INCOME-PRETAX>                          275,504
<INCOME-TAX>                             106,000
<INCOME-CONTINUING>                      169,504
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                             169,504
<EPS-BASIC>                                 0.07
<EPS-DILUTED>                               0.07



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission